These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hyperkalemia in hypertensive patients undergoing regular hemodialysis during enalapril and fosinopril therapy]. Dimković N; Djordjević T; Popović J; Dimković S; Tirmenstajn-Janković B; Zivanović M; Bobanović-Hasković J Srp Arh Celok Lek; 2006; 134(1-2):44-8. PubMed ID: 16850577 [TBL] [Abstract][Full Text] [Related]
3. Reversible hyperkalemia during antihypertensive therapy in a hypertensive diabetic patient with latent hypoaldosteronism and mild renal failure. Uchida K; Azukizawa S; Nakano S; Kaneko M; Kigoshi T; Morimoto S; Matsui A South Med J; 1994 Nov; 87(11):1153-5. PubMed ID: 7973905 [TBL] [Abstract][Full Text] [Related]
4. [Development of renal function in the transplanted patient with renal hypertension treated with enalapril]. Guerin C; Genin C; Sabatier JC; Toulon J; Leroy G; Berthoux F Nephrologie; 1987; 8(1):19-22. PubMed ID: 3035397 [TBL] [Abstract][Full Text] [Related]
5. Treatment of dialysis resistant hypertension with enalapril. Sennesael J; Verbeelen D Acta Cardiol; 1986; 41(5):367-71. PubMed ID: 3022513 [No Abstract] [Full Text] [Related]
6. Reversible impairment of renal function associated with enalapril in a diabetic patient. Albareda MM; Corcoy R CMAJ; 1998 Nov; 159(10):1279-81. PubMed ID: 9861226 [TBL] [Abstract][Full Text] [Related]
7. Enalapril in the treatment of hypertension associated with impaired renal function. Cooper WD; Doyle GD; Donohoe J; Laher M; Ledingham JG; Raine AE; Melinck C; Unsworth J; Raman GV; VandenBurg MJ J Hypertens Suppl; 1985 Dec; 3(3):S471-4. PubMed ID: 2856770 [TBL] [Abstract][Full Text] [Related]
9. Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients. Sakallı H; Baskın E; Bayrakcı US; Moray G; Haberal M Exp Clin Transplant; 2014 Aug; 12(4):310-3. PubMed ID: 24447308 [TBL] [Abstract][Full Text] [Related]
10. [Captopril and enalapril in the treatment of renal hypertension]. Hasanagić H; Djukanović Lj; Subotić Z; Nesić V; Cavrić G Srp Arh Celok Lek; 1990; 118(7-8):285-90. PubMed ID: 2097777 [TBL] [Abstract][Full Text] [Related]
11. [Renal effects of angiotensin-converting enzyme inhibitors and their therapeutic use in chronic terminal renal failure]. Ritz E; Mann JF; Rambausek M Z Kardiol; 1988; 77 Suppl 3():57-60. PubMed ID: 2850688 [No Abstract] [Full Text] [Related]
12. [Severe electrolyte disorders during the therapy of heart failure with the therapy of heart failure with the ACE-inhibitor enalapril]. Hess B; Keusch G; Neftel K; Margelist F; Bansky G Schweiz Med Wochenschr; 1986 Sep; 116(39):1331-6. PubMed ID: 3022372 [TBL] [Abstract][Full Text] [Related]
13. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil. Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294 [TBL] [Abstract][Full Text] [Related]
14. [Lactic acidosis and severe hyperkalemia in a diabetic patient treated with metformin and enalapril: influence of acute renal disease and drugs]. Franzetti I; Donnini P; Gaiazzi M; Mazzola E; Zibetti E; Uccella R Minerva Med; 1995; 86(1-2):49-54. PubMed ID: 7753438 [TBL] [Abstract][Full Text] [Related]
15. Diuretics potentiate the angiotensin converting-enzyme inhibitor-associated acute renal dysfunction. Lee HC; Pettinger WA Clin Nephrol; 1992 Oct; 38(4):236-7. PubMed ID: 1424316 [No Abstract] [Full Text] [Related]